,outcome,arm 1,arm 2
0,intervention,pioglitazone,glimepirede
0,"intent-to-treat, reductions in HbA ( 1c ) from baseline to the end of the study",-0.78 %,NR
0,reductions in HbA ( 1c ) from baseline to the end of the study,NR,-0.68 %
